| The pivotal link between ACE2 deficiency and SARS-CoV-2 infection P Verdecchia, C Cavallini, A Spanevello, F Angeli European journal of internal medicine 76, 14-20, 2020 | 1220 | 2020 |
| Adverse prognostic significance of new diabetes in treated hypertensive subjects P Verdecchia, G Reboldi, F Angeli, C Borgioni, R Gattobigio, L Filippucci, ... Hypertension 43 (5), 963-969, 2004 | 638 | 2004 |
| Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention P Verdecchia, G Reboldi, F Angeli, R Gattobigio, M Bentivoglio, L Thijs, ... Hypertension 46 (2), 386-392, 2005 | 514 | 2005 |
| Atrial fibrillation in hypertension: predictors and outcome P Verdecchia, GP Reboldi, R Gattobigio, M Bentivoglio, C Borgioni, ... hypertension 41 (2), 218-223, 2003 | 497 | 2003 |
| Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial P Verdecchia, JA Staessen, F Angeli, G De Simone, A Achilli, A Ganau, ... The Lancet 374 (9689), 525-533, 2009 | 480 | 2009 |
| Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis P Verdecchia, F Angeli, C Borgioni, R Gattobigio, G De Simone, ... American Journal of Hypertension 16 (11), 895-899, 2003 | 439 | 2003 |
| Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients G Reboldi, G Gentile, F Angeli, G Ambrosio, G Mancia, P Verdecchia Journal of hypertension 29 (7), 1253-1269, 2011 | 383 | 2011 |
| Short-and long-term incidence of stroke in white-coat hypertension P Verdecchia, GP Reboldi, F Angeli, G Schillaci, JE Schwartz, ... Hypertension 45 (2), 203-208, 2005 | 380 | 2005 |
| Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications P Verdecchia, F Angeli, G Mazzotta, M Garofoli, E Ramundo, G Gentile, ... Hypertension 60 (1), 34-42, 2012 | 344 | 2012 |
| Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension P Verdecchia, F Angeli, R Gattobigio, C Rapicetta, G Reboldi American journal of hypertension 20 (2), 154-161, 2007 | 271 | 2007 |
| Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis G Reboldi, F Angeli, C Cavallini, G Gentile, G Mancia, P Verdecchia Journal of hypertension 26 (7), 1282-1289, 2008 | 243 | 2008 |
| Association between periodontal disease and left ventricle mass in essential hypertension F Angeli, P Verdecchia, C Pellegrino, RG Pellegrino, G Pellegrino, ... Hypertension 41 (3), 488-492, 2003 | 186 | 2003 |
| Hypertension and atrial fibrillation: doubts and certainties from basic and clinical studies P Verdecchia, F Angeli, G Reboldi Circulation Research 122 (2), 352-368, 2018 | 181 | 2018 |
| Ambulatory blood pressure and cardiovascular outcome in relation to perceived sleep deprivation P Verdecchia, F Angeli, C Borgioni, R Gattobigio, G Reboldi Hypertension 49 (4), 777-783, 2007 | 177 | 2007 |
| Blood pressure monitoring in cardiovsacular medicine and therapeutics WB White Humana Pr Inc, 2007 | 170 | 2007 |
| Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects P Verdecchia, G Reboldi, C Porcellati, G Schillaci, S Pede, M Bentivoglio, ... Journal of the American College of Cardiology 39 (5), 878-885, 2002 | 166 | 2002 |
| Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects F Angeli, P Verdecchia, GP Reboldi, R Gattobigio, M Bentivoglio, ... American journal of hypertension 17 (9), 817-822, 2004 | 159 | 2004 |
| Masked hypertension: evaluation, prognosis, and treatment F Angeli, G Reboldi, P Verdecchia American journal of hypertension 23 (9), 941-948, 2010 | 147 | 2010 |
| Electrocardiographic features of patients with COVID-19 pneumonia F Angeli, A Spanevello, R De Ponti, D Visca, J Marazzato, G Palmiotto, ... European journal of internal medicine 78, 101-106, 2020 | 140 | 2020 |
| The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction P Verdecchia, F Angeli, G Mazzotta, G Gentile, G Reboldi Vascular health and risk management 4 (5), 971-981, 2008 | 134 | 2008 |
Gianpaolo (Paolo) ReboldiDepartment of Medicine, University of Perugia, ITALY在 unipg.it 的电子邮件经过验证
